Discover how this $1,000 injection is reprogramming appetite, outperforming Ozempic, and reshaping the future of obesity treatment.

If you’ve spent any time online, you’ve probably heard of the transformative results of Novo Nordisk’s Ozempic or Wegovy. Powered by an Active Pharmaceutical Ingredient (API) called Semaglutide, it is promoted by celebrities and has a strong social media presence. In contrast, while Eli Lilly’s (refers to as Lilly) Zepbound and Mounjaro are powered by Tirzepatide, a superior drug with stronger clinical results, helping Lilly to become the global weight loss mareket leader (“Advanced Pharmaceutical Manufacturing Tech Hub,” 2024). This market is projected to reach $405.4B by 2030, with a compound growth rate of 6.8% (2024_BiopharmaFundingReport.pdf, 2024).

Semaglutide VS Tirzepatide, a clinical face off

To understand why Tirzepatide outperforms its competitors, we need to zoom in past fat cells and blood vessels, into the gut. Semgalutide is an API that mimics only GLP-1, while Tirzepatide acts as a dual agonist, mimicking both GIP and GLP-1 hormones.

GLP-1 = Glucagon-Like Peptide-1

• Produced by L-cells in the lower small intestine and colon after the ingestion of food, particularly those high-fibre grains, lean meat, and yogurt (Pedersen, 2024).
• GLP-1 is produced and secreted into the bloodstream, primarily to:
  • Stimulate the release of insulin, suppressing glucagon to reduce blood sugar spikes
  • Slows down digestion
  • Increase satiety (fullness)

GIP = Glucose-Dependent Insulinotropic Polypeptide

• Produced by k-cells in the upper small intestine (duodenum and jejunum) due to foods like high in carbohydrates and proteins (Pedersen, 2024).
• Secreted into the bloodstream primarily to:
  • Increase insulin release
  • Supports fat storage and metabolism

Semaglutide mimics only GLP-1, explaining its appetite suppressing power. However, Tirzepatide mimics both GLP-1 and GIP. This dual-agnoist acitons boosts the body’s ablity to feel full faster, reduce creavings more effectively, improve insulin sensitivity, and burn calories more efficiently.

How does Tirzepatide work?

• Tirzepatide mimics both GLP-1 and GIP hormones by:
  • Binding to GLP-1 and GIP receptors in the pancreas, gut, and brain
  • Enhances insulin release and reduces hunger signals more strongly than GLP-1 drug alone
• Results: it’s effectiveness in promoting satiety, patients experience less appetite, leading to lower caloric intake and subsequent weight loss. Additionally, studies have also shown that it reduces fast food cravings, supporting the adoption of healthier and more sustainable diets.

In short, Tirzepatide doesn’t just suppress hunger, it rewires it.

Hijacking the gut and brain: how Tirzepatide is reprograming hunger

What makes Tirzepatide so effectiveness isn’t just its impressive weight loss achievements, its how it changes the body’s internal communication.

By interacting with the receptors in both the gut and the brain, Tizepatide effectively increases fullness signals, lowering hunger hormones like Ghrelin. Many patients and clinical studies also report a reduce in cravings, that they no longer obsess over food and have increased tolerance for healthier foods. Others say they can go hours without eating and not feeling deprived (Eli Lilly and Company, 2024). However, some medical professionals express concern about its possible side effects on metabolism and its ethical issues related to the promotion of unhealthy weight standards.

This reveals a critical insight about weight loss: obesity isn’t just about how much you eat, its about what you eat. Each food has different nutritional values, which triggers and responds differently to biochemical signals. It also shows how the brain not only responds to what you eat, but is greatly influenced by gut hormones, insulin dynamics, and even inflammation.

The $1000 question: Who Gets Access?

With all brandname weight loss injection drugs being priced above $1000, including Ozempic, Wegovy, Zepbound, and Tirzepatide, access remains a major challenge. Having invested massive funds into the Research & Development (Mikulic, 2025b) of these drugs, pharmaceutical companies only have 10-12 years to maximize profits and generate returns on their investments before it loses its patent protections and have increased competition by generic drug manufacturers (Lilly Reports Full Q4 2024 Financial Results and Provides 2025 Guidance | Eli Lilly and Company, 2024). Therefore, prices must remain high. However, for some U.S insured patients may be eligble for Lilly’s special ‘Copay card’, allowing them access to the $1059 zepbound for just $25 (Eli Lilly and Company, 2024). Lilly has also tried to increase accesibility through LillyDirect, an online platform offering medical consultants, perscirptions, and medical servives, with up to 20% manufacturer discount price for purchases Zepbound (Eli Lilly and Company, 2024).

Beyond the U.S, Lilly uses tired pricing and international price discrimination strategies to make the drug more affordable in lower-income countries through negotiation with the government and local partnerships (Amin et al., 2023).

Despite their efforts, access to these drugs still remain a challenge for manny middle-low income individuals.

Is it possible to regulate hunger hormones without the shot?

While drugs like Tizepatides are powerful tools, they aren’t the only solution to control hormones, appetite, and fat storage. Here are some simple ways to support the body’s production and response to GIP, GLP-1, grhelin, and insulin, just like the weight loss shots:

1. Eat more protein and fibre
   • How it helps: Proteins and fibres boost GLP-1 and PYY (another satiety hormone), while slowing gastric emptying. Proteins also burn more calories to digest than simple carbohydrates like bread
   • Examples: Lean meat, fish, lentils, leafy greens, or greek yogurt
   • Tip! Try ordered eating: start your meal off with salad or some vegetables to reduce insulin spikes and promote fullness. This can prevent overeating and control appetite.
2. Consistent exercise
   • How it helps: While this may seem common, it is actually extremely crucial for sustainable weight loss, preserving muscle mass while promoting fat loss. Regular movements improves insulin sensitivity, reduces inflammation and may help lower ghrelin levels (a hormone that stimulate hunger)
   • Tip! go for aerobic exercises like taking a 20 minute walk after every meal to easily hit 10k steps. This low intensity activity supports digestion and unlike cardio, it doesn’t lead to increased hunger, helping you stay within your calorie goals
3. Prioritize sleep
   • How it helps: Sleep deprivation increases ghrelin and decreases leptin (a hormone that makes you feel full), disrupting appetite control
   • Aim for 7-9 hours of quality sleep to easily see the scale go down and support metabolic hormone balance. This will also aid with decreased mood swings and cravings, making you feel more refreshed and energized throughout the day.

Scientific turning point

The science behind these weight loss drugs, particularly Lilly’s Tirzepatide, is broadening our understanding of how to treat obesity. For decades, weight loss was seen as a matter of willpower, with little recognition of the complex biological and psychological factors involved. As a result, many turned to extreme calorie deficits and unsustainable diets, often falling into the cycle of “yo-yo” dieting and ultimately giving up. Now, with these medications becoming more widely available, more people have a real chance at achieving lasting change. However, while these drugs offer new hope, they are not a cure-all; long-term success still depends on adopting sustainable lifestyle habits alongside medical treatment.